These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 7878763

  • 21. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
    Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec-Weglinski JW.
    J Immunol; 1997 Feb 15; 158(4):1572-81. PubMed ID: 9029092
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J, Lehmann M, Graser E, Hancock WW, Watschinger B, Onodera K, Sayegh MH, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1996 Mar 15; 61(5):804-11. PubMed ID: 8607187
    [Abstract] [Full Text] [Related]

  • 24. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C, Reiss GR, Mohiuddin M, Shen Z, Yokoyama H, DiSesa VJ.
    J Surg Res; 1996 Jun 15; 63(1):83-5. PubMed ID: 8661177
    [Abstract] [Full Text] [Related]

  • 25. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
    de Bruin RW, van Rossum TJ, Scheringa M, Bonthuis F, IJzermans JN, Marquet RL.
    Transplantation; 1995 Nov 15; 60(9):1061-3. PubMed ID: 7491686
    [No Abstract] [Full Text] [Related]

  • 26. Infectious tolerance develops after intrathymic alloantigen-induced acceptance of rat heart allografts can be adoptively transferred.
    Takayashiki T, Asakura H, Ku G, Kataoka M, Flye MW.
    Surgery; 2005 Aug 15; 138(2):254-60. PubMed ID: 16153434
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB.
    Transplantation; 1993 May 15; 55(5):1112-8. PubMed ID: 8497891
    [Abstract] [Full Text] [Related]

  • 29. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD, Gandy KL, Morris RE, Hoyt G, Gutierrez J, Reitz BA, Robbins RC.
    J Heart Lung Transplant; 1995 May 15; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [Abstract] [Full Text] [Related]

  • 30. Significant changes in the alloantibody after lung transplantation in the cyclosporine treated rat model.
    Yamane M, Sano Y, Shimizu N.
    Transpl Immunol; 2004 Jan 15; 12(2):143-50. PubMed ID: 14967312
    [Abstract] [Full Text] [Related]

  • 31. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD, Van Breda Vriesman PJ.
    Transplantation; 1983 Feb 15; 35(2):121-6. PubMed ID: 6338632
    [Abstract] [Full Text] [Related]

  • 32. [Immune tolerance induced by combined heart-thymus transplantation with intrathymic inoculation of thymocytes in rats].
    Xiong HB, Xia SS, Huang ZF, Wen H, Ye QF.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb 15; 31(1):85-90. PubMed ID: 16562683
    [Abstract] [Full Text] [Related]

  • 33. The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats.
    Coito AJ, Binder J, de Sousa M, Kupiec-Weglinski JW.
    Transplantation; 1994 Feb 27; 57(4):599-605. PubMed ID: 8116048
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K, Hancock WW, Osawa H, Stunkel KG, Alberghini TV, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    J Immunol; 1989 Nov 01; 143(9):2873-9. PubMed ID: 2530281
    [Abstract] [Full Text] [Related]

  • 35. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye MW.
    Surgery; 2000 Aug 01; 128(2):206-12. PubMed ID: 10922993
    [Abstract] [Full Text] [Related]

  • 36. Successful experimental heart transplantation without immunosuppressive drugs.
    Kline GM, Shen Z, Mohiuddin M, Ruggiero V, Rostami S, DiSesa VJ.
    J Heart Lung Transplant; 1993 Aug 01; 12(3):388-93. PubMed ID: 8329408
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Fetal inoculation with donor cells in cardiac xenotransplantation.
    Shen Z, Mohiuddin M, DiSesa VJ.
    Ann Thorac Surg; 1996 Nov 01; 62(5):1360-3. PubMed ID: 8893569
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.